期刊文献+

雷公藤甲素对类风湿关节炎滑膜成纤维细胞系MH7A中VEGF、MMP-9水平变化的影响 被引量:42

Effect of triptolide on the changes of VEGF and MMP-9 levels in the rheumatoid arthritis fibroblast-like synoviocyte line,MH7A
下载PDF
导出
摘要 目的:研究雷公藤甲素对类风湿关节炎(RA)滑膜成纤维细胞系MH7A培养上清液中血管内皮生长因子(VEGF)、基质金属蛋白酶-9(MMP-9)水平变化的影响。方法:肿瘤坏死因子-α(TNF-α)刺激RA滑膜成纤维细胞系MH7A后,以不同剂量TP干预,酶联免疫吸附试验(ELISA)检测细胞培养液上清中VEGF、MMP-9水平的变化。结果:TNF-α刺激后,细胞培养上清液中VEGF及MMP-9分泌不同程度增加。TP各剂量组(1、5、25、75μg/ml)在不同时间点(24、48、72h)均可以明显下调培养上清液中MMP-9和VEGF的水平,与地塞米松对照组比有显著差异。结论:雷公藤甲素能抑制血管新生有关细胞因子VEGF、MMP-9的表达。 Objective:To study the effect of triptolide on the expression of VEGF and MMP-9 in the rheumatoid arthritis fibroblast-like synoviocyte line,MH7A. Methods:Rheumatoid arthritis fibroblast-llke synoviocyte line,MH7A were incubated for 24 hours with 20 ng/ ml of recombinant human TNF-α then were treated with Triptolide of different concentration( 1μg/ml,5 μg/ml, 25 μg/ml and 75 μg/ml). Levels of vascular endothelial growth factor(VEGF) and matrix metallproteinases(MMP-9)were measured in cell supernatants by Enzyme- Linked ImmunoSorbent Assay (ELISA). Results:After TNFct stimulation, VEGF and MMP-9 production was highly increased in the supernatants. Triptolide caused a dose-dependent decrease in VEGF and MMP-9. The inhibited effect of Triptolide on the expression of VEGF and MMP-9 is stronger than that of Dexamethasone. Conclusion: Triptolide can inhibit the regulative factor of angiogenesis VEGF and MMP-9 expression.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2008年第7期902-905,共4页 Journal of Nanjing Medical University(Natural Sciences)
关键词 雷公藤甲素 类风湿性关节炎 血管内皮生长因子 基质金属蛋白酶-9 Triptolide rheumatoid arthritis vascular endothelial growth factor(VEGF) matrix metallproteinases(MMP-9)
  • 相关文献

参考文献13

  • 1Paleolog EM, Miotla JM. Rheumatoid arthritis : A target for antiangigenic therapy [J]. Humana Press In, 2001,8 (6) : 129-149
  • 2Okada Y, Nagase H, Harris ED. A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components [J]. J Biol Chem,1986,26(1):14245-14255
  • 3Keiji Miyazawa,Akio Mori,Hirokazu Okudaira. Establishment and characterization of a novel human rheumatoid fibroblast-like synoviocyte line,MH7A,immortalized with SV40 T Antigen [ J]. J Biochem, 1998,124 (6): 1153- 1162
  • 4Lard LR,Visser H,Speyer I,et al. Early vs delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies [J ]. Am J Med, 2003,111 (6): 446-451
  • 5Bathon JM,Martin RW,Fleischmann RM,et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis [J]. N Engl J Med,2000,343 (22) : 1586-1193
  • 6Keystone EC, Kavanaugh AF,Sharp JT, et al. Radiographic,clinical,and functional outcomes of treatment with adalimumab (a human anti-tumour necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy:a randomized,placebo-controlled,52-week trial [J]. Arthritis Rheum,2004,50(5) : 1400-1411
  • 7Maini RN,Breedveld FC,Kalden JR,et al. Anti-tumour necrosis factor trial in rheumatoid arthritis with concomitant therapy study group. Sustained improvement over two years in physical function,structural damage,and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate [J]. Arthritis Rheum,2004,50(4) : 1051-1065
  • 8Koch AE. Angiogenesis as a target in rheumatoid arthritis [J]. Ann Rheum Dis,2003,62(suppl 2):ii60-67
  • 9Clauss M. Molecular biology of the VEGF and the VEGF receptor family[J]. Semin Thromb Hemost,2000,26(5) : 561-569
  • 10Giannelli G,Erriquez R,Iannone F. MMP-2,MMP-9, TIMP-1 and TIMP-2 levels in patients with rheumatoid arthritis and psorimic arthritis [J]. Clin Exp Rheumatol, 2004,22(3) :335-338

共引文献371

同被引文献749

引证文献42

二级引证文献579

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部